|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Share-based compensation expense | |||||
| Depreciation and amortization | |||||
| Non-cash operating leases expense | |||||
| Amortization of premium on short-term investments | |||||
| Gain on sale of equity method investment | |||||
| Impairment of other financial instruments | |||||
| Executive chairman long-term performance award | |||||
| Non-cash postcombination compensation expense | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Settlements receivable | |||||
| Network incentives receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Revenue share payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Restricted cash acquired in business combination | |||||
| Maturities of short-term investments | |||||
| Cash paid for business acquisition, net of cash acquired | |||||
| Purchase of patents | |||||
| Capitalization of internal-use software | |||||
| Purchases of short-term investments | |||||
| Purchases of property and equipment | |||||
| Sales of short-term investments | |||||
| Realized loss on investments | |||||
| Purchase of equity method investment and purchase option | |||||
| Sale of equity method investment | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from initial public offering, net of underwriters’ discounts and commissions | |||||
| Repurchase of common stock | |||||
| Payment of deferred offering costs | |||||
| Taxes paid related to net share settlement of restricted stock units | |||||
| Change in funds payable and amounts due to customers | |||||
| Proceeds from shares issued in connection with employee stock purchase plan | |||||
| Proceeds from exercise of stock options, including early exercised stock options, net of repurchase of early exercised unvested options | |||||
| Payment of acquisition-related contingent consideration | |||||
| Proceeds from exercise of warrants | |||||
| Net cash used in financing activities | |||||
| Increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash - Beginning of period | |||||
| Cash, cash equivalents, and restricted cash - End of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for operating lease liabilities | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Share-based compensation capitalized to internal-use software | |||||
| Contingent and holdback considerations, not yet paid | |||||
| Operating lease right-of-use assets in exchange for lease liabilities | |||||
| Repurchase of common stock, including excise tax, accrued and not yet paid | |||||
| Vesting of early exercised stock options | |||||
| Purchase of property and equipment accrued and not yet paid | |||||
| Reconciliation of cash, cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Restricted cash, included in Other assets | |||||
Loading...